Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine densities in brain regions important to zebra finch vocal learning and production in an antidepressant-sensitive manner

Brain Res. 2017 Oct 1:1672:1-9. doi: 10.1016/j.brainres.2017.07.015. Epub 2017 Jul 22.

Abstract

During typical late-postnatal CNS development, net reductions in dendritic spine densities are associated with activity-dependent learning. Prior results showed agonist exposure in young animals increased spine densities in a subset of song regions while adult exposures did not, suggesting endocannabinoid signaling regulates dendritic spine dynamics important to vocal development. Here we addressed this question using the CB1 receptor-selective antagonist SR141716A (SR) to disrupt endocannabinoid signaling both during and after vocal learning. We hypothesized antagonist exposure during vocal development, but not adulthood, would alter spine densities. Following 25days of exposure and a 25day maturation period, 3D reconstructions of Golgi-Cox stained neurons were used to measure spine densities. We found antagonist treatments during both age periods increased densities within Area X (basal ganglia) and following adult treatments within HVC (premotor cortical-like). Results suggest both inappropriate cannabinoid receptor stimulation and inhibition are capable of similar disregulatory effects during establishment of circuits important to vocal learning, with antagonism extending these effects through adulthood. Given clinical evidence of depressant effects of SR, we tested the ability of the antidepressant monoamine oxidase inhibitor (MAOI) phenelzine to mitigate SR-induced spine density increases. This was confirmed implicating interaction between monoamine and endocannabinoid systems. Finally, we evaluated acute effects of these drugs to alter ability of novel song exposure to increase spine densities in auditory NCM and other regions, finding when combined, SR and phenelzine increased densities within Area X. These results contribute to understanding relevance of dendritic spine dynamics in neuronal development, drug abuse, and depression.

Keywords: CNS development; Cannabinoid; Dendritic spines; MAOI; SR141716A; Vocal learning.

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Brain / drug effects
  • Brain / physiology
  • Cannabinoid Receptor Antagonists / metabolism
  • Cannabinoids / pharmacology
  • Dendritic Spines / drug effects*
  • Endocannabinoids / pharmacology
  • Finches / metabolism
  • Finches / physiology
  • Learning / physiology
  • Male
  • Monoamine Oxidase Inhibitors / pharmacology
  • Neurogenesis / drug effects
  • Receptor, Cannabinoid, CB1 / antagonists & inhibitors*
  • Receptor, Cannabinoid, CB1 / metabolism*
  • Vocalization, Animal / drug effects*
  • Vocalization, Animal / physiology

Substances

  • Antidepressive Agents
  • Cannabinoid Receptor Antagonists
  • Cannabinoids
  • Endocannabinoids
  • Monoamine Oxidase Inhibitors
  • Receptor, Cannabinoid, CB1